Aurobindo Pharma’s subsidiary -- Aurobindo Pharma USA Inc is recalling 80 lots of tablets used for treatment of high blood pressure and heart failure from the American market which include Amlodipine Valsartan tablets USP, Valsartan HCTZ tablets USP and Valsartan tablets USP. This is done due to presence of impurity found in the finished drug product that may cause cancer in humans.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
